Nitto Denko Corp
TSE:6988
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 306
4 068
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Nitto Denko Corp
Nitto Denko Corp., a trailblazer in the world of advanced material manufacturing, has carved a niche for itself by transforming everyday convenience and innovation. Rooted in its Japanese heritage, the company has evolved from its beginnings in 1918 as a modest producer of electrical insulation materials to becoming a multifaceted global powerhouse. Today, Nitto's portfolio stretches across a wide spectrum of industries, including electronics, healthcare, and automotive, each segment contributing to its diversified revenue streams. The secret to its success lies in a commitment to research and development, resulting in breakthrough products like polarizing films for LCD screens, which are indispensable to the visual clarity of digital devices, and specialized adhesives that find applications in automotive and medical fields.
What sets Nitto Denko apart is its ability to anticipate market demands and innovate accordingly. The company's revenue generation can be attributed to its robust production of advanced optical films and industrial tapes, both critical components in consumer electronics and automotive manufacturing. Additionally, its investment in life sciences has led to lucrative ventures in transdermal drug delivery systems, showcasing its adaptability in the healthcare sector. By leveraging its technological expertise and strategic foresight, Nitto continues to maintain a competitive edge, ensuring steady growth and sustainability in rapidly evolving markets.
Nitto Denko Corp., a trailblazer in the world of advanced material manufacturing, has carved a niche for itself by transforming everyday convenience and innovation. Rooted in its Japanese heritage, the company has evolved from its beginnings in 1918 as a modest producer of electrical insulation materials to becoming a multifaceted global powerhouse. Today, Nitto's portfolio stretches across a wide spectrum of industries, including electronics, healthcare, and automotive, each segment contributing to its diversified revenue streams. The secret to its success lies in a commitment to research and development, resulting in breakthrough products like polarizing films for LCD screens, which are indispensable to the visual clarity of digital devices, and specialized adhesives that find applications in automotive and medical fields.
What sets Nitto Denko apart is its ability to anticipate market demands and innovate accordingly. The company's revenue generation can be attributed to its robust production of advanced optical films and industrial tapes, both critical components in consumer electronics and automotive manufacturing. Additionally, its investment in life sciences has led to lucrative ventures in transdermal drug delivery systems, showcasing its adaptability in the healthcare sector. By leveraging its technological expertise and strategic foresight, Nitto continues to maintain a competitive edge, ensuring steady growth and sustainability in rapidly evolving markets.
Revenue Decline: FY 2018 net sales fell 5.9% year-on-year to JPY 806.5 billion, driven by lower sales volume and price reductions.
Profit Drop: Operating profit decreased by 26.2% to JPY 92.8 billion, and net profit declined 23.8% to JPY 66.6 billion, mainly due to volume, pricing, and cost pressures.
2019 Guidance: FY 2019 guidance is for further declines: net sales to JPY 790 billion (down 2%), operating profit to JPY 85 billion (down 8.4%), and net profit to JPY 62 billion (down 6.9%).
Segment Variance: Industrial Tape expected to grow slightly in sales and jump in profit, while Optronics and Life Science are forecast to decline.
Capital & R&D Investment: Record-high capital investment of JPY 75 billion and R&D spending of JPY 33 billion planned to support growth themes and new business development.
Increased Dividend: Annual dividend for FY 2019 planned at JPY 200 per share, up JPY 20 from the previous year.
Strategic Focus: Emphasis on next-generation mobility, information interface, and life sciences, with ongoing investments in product and technology innovation.